New Multiple Sclerosis Pill Offers Great Promise

April 30, 2009

(ChattahBox)—The results of a two-year clinical study conducted in the UK, treating Multiple Sclerosis patients with cladribine pills, shows great promise for the future treatment of patients suffering from the debilitating neurological disease. The clinical study treated MS patients with a course of the pills, just a few times a year and the results were amazing. The patients experienced a reduction in disease relapses by a whopping 55 percent.

Multiple sclerosis is a devastating neurological disease that affects many young women in the prime of their lives. Current treatments involved injections, which many would like to do without. Now with this new first of its kind pill therapy, patients will have additional treatment options.

The study treated 1,300 MS patients with doses of the cladribine pills, over a two year period. Some patients received placebos and others received two or four treatment courses of cladribine tablets per year, with each typical course lasting up to five days.

Compared with the placebo group, the patients receiving clabribine, showed remarkable improvement, enjoying 55 percent less relapses and a 30 percent reduction in the progression of MS. Patients also showed minimal side effects from the pills.

Lead researcher, Professor Gavin Giovannoni of Barts and The London School of Medicine, is excited by the results and hopes to make the treatment available to the public soon.



Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of - Comments are the opinions of the individuals leaving them, and not of or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.